A new study published in the journal of Arthritis & Rheumatology showed that interstitial lung disease (ILD) can occur in ...
Addressing sleep-related complaints may enhance symptomatic treatment and management of PAH. Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was ...
Pulmonary arterial hypertension (PAH) is one of five types of pulmonary hypertension. It happens when the blood vessels in your lungs narrow and scar so much that it’s hard for blood to move ...
Patients at particular risk for postoperative pulmonary hypertension can be identified ... PHTN is defined as a systolic pulmonary arterial pressure (PAP) of >35 mm Hg or a mean PAP of >25 mm ...
If you have pulmonary arterial hypertension (PAH), it’s possible to lead an active, productive life. The key is to work closely with a specialist, usually a lung doctor (pulmonologist ...
In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.
Supervised pulmonary rehabilitation exercises help severe PAH lung transplant candidates maintain or improve exercise ...
"We are excited about the prospects of a novel treatment option for patients who are suffering from pulmonary arterial hypertension," said Dr. John Granton, Director of the Pulmonary Hypertension (PH) ...
Inhibikase Therapeutics (IKT) has received a new Buy rating, initiated by Jefferies analyst, Dennis Ding. Dennis Ding has given his Buy rating ...
Therapies that target the prostacyclin pathway hold promise as chronic CTEPH treatment, a meta-analysis of controlled trials ...
Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...
Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...